Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Kazia Therapeutics Limited (KZIA)

Compare
3.3000
-0.2330
(-6.59%)
At close: April 17 at 4:00:00 PM EDT
3.1300
-0.17
(-5.15%)
After hours: April 17 at 7:25:54 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for KZIA

Recent News: KZIA

View More
Kazia Therapeutics Announces Sale of Intellectual Property and Trademarks Rights for Cantrixil

Kazia Therapeutics Announces Sale of Intellectual Property and Trademarks Rights for Cantrixil
PR Newswire 19 days ago
Kazia Therapeutics and the Hebrew University of Jerusalem Receives a Grant from The Michael J. Fox Foundation to Evaluate the Therapeutic Potential of Paxalisib as a Treatment for Parkinson's Disease

Kazia Therapeutics and the Hebrew University of Jerusalem Receives a Grant from The Michael J. Fox Foundation to Evaluate the Therapeutic Potential of Paxalisib as a Treatment for Parkinson's Disease
PR Newswire last month
Is Kazia Therapeutics (KZIA) One of the Best ASX Stocks to Buy According to Hedge Funds?

Is Kazia Therapeutics (KZIA) One of the Best ASX Stocks to Buy According to Hedge Funds?
Insider Monkey 2 months ago
Kazia Therapeutics announces the launch of a groundbreaking trial with paxalisib in combination with immunotherapy in women with advanced breast cancer

Kazia Therapeutics announces the launch of a groundbreaking trial with paxalisib in combination with immunotherapy in women with advanced breast cancer
PR Newswire 2 months ago
Why Kazia Therapeutics (KZIA) Is Among the Best Australian Stocks to Buy Now?

Why Kazia Therapeutics (KZIA) Is Among the Best Australian Stocks to Buy Now?
Insider Monkey 2 months ago
Kazia Therapeutics Announces Closing of $2.0 Million Registered Direct Offering

Kazia Therapeutics Announces Closing of $2.0 Million Registered Direct Offering
PR Newswire 3 months ago
Kazia Therapeutics to sell 1.33M ADS at $1.50 in registered direct offering

Kazia Therapeutics to sell 1.33M ADS at $1.50 in registered direct offering
TipRanks 3 months ago
Kazia Therapeutics Announces $2.0 Million Registered Direct Offering

Kazia Therapeutics Announces $2.0 Million Registered Direct Offering
PR Newswire 3 months ago
Why Is Brain Cancer-Focused Kazia Therapeutics Stock Trading Lower On Tuesday?

Why Is Brain Cancer-Focused Kazia Therapeutics Stock Trading Lower On Tuesday?
Benzinga 3 months ago
Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA

Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA
PR Newswire 3 months ago
Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast Cancer Symposium

Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast Cancer Symposium
PR Newswire 4 months ago
View More

Related Tickers

TVRD Tvardi Therapeutics, Inc.
17.04
-5.65%
 
QNRX Quoin Pharmaceuticals, Ltd.
5.48
-7.46%
 
GRI GRI Bio, Inc.
1.5100
-1.31%
 
NAYA INVO Fertility, Inc.
1.9200
+4.35%
 
APM Aptorum Group Limited
0.8313
-9.03%
 
CDT Conduit Pharmaceuticals Inc.
0.6201
-20.51%
 
ONCO Onconetix, Inc.
0.0595
-0.17%
 
ZVSA ZyVersa Therapeutics, Inc.
0.6991
-1.89%
 
CHRO Channel Therapeutics Corporation
1.8400
+46.61%
 
CMND Clearmind Medicine Inc.
1.1200
+15.46%